1
|
González Mesa JE, Alem Glison D, Chaves-Campos FA, Ortíz Morales F, Valle Bourrouet L, Abarca Ramírez M, Verdejo V, Di Giorgio M, Radl A, Taja MR, Deminge M, Rada-Tarifa A, Lafuente-Alvarez E, Lima FFD, Hwang S, Esposito Mendes M, Mandina-Cardoso T, Muñoz-Velastegui G, Guerrero-Carbajal YC, Arceo Maldonado C, Monjagata N, Aguilar-Coronel S, Espinoza-Zevallos M, Falcon de Vargas A, Vittoria Di Tomaso M, Holladay B, Lima OG, Martínez-López W. LBDNet interlaboratory comparison for the dicentric chromosome assay by digitized image analysis applying weighted robust statistical methods. Int J Radiat Biol 2024; 100:1019-1028. [PMID: 38810111 DOI: 10.1080/09553002.2024.2356556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2023] [Accepted: 05/13/2024] [Indexed: 05/31/2024]
Abstract
PURPOSE This interlaboratory comparison was conducted to evaluate the performance of the Latin-American Biodosimetry Network (LBDNet) in analyzing digitized images for scoring dicentric chromosomes from in vitro irradiated blood samples. The exercise also assessed the use of weighted robust algorithms to compensate the uneven expertise among the participating laboratories. METHODS Three sets of coded images obtained through the dicentric chromosome assay from blood samples irradiated at 1.5 Gy (sample A) and 4 Gy (sample B), as well as a non-irradiated whole blood sample (sample C), were shared among LBDNet laboratories. The images were captured using the Metafer4 platform coupled with the AutoCapt module. The laboratories were requested to perform triage scoring, conventional scoring, and dose estimation. The dose estimation was carried out using either their laboratory calibration curve or a common calibration curve. A comparative statistical analysis was conducted using a weighted robust Hampel algorithm and z score to compensate for uneven expertise in dicentric analysis and dose assessment among all laboratories. RESULTS Out of twelve laboratories, one had unsatisfactory estimated doses at 0 Gy, and two had unsatisfactory estimated doses at 1.5 Gy when using their own calibration curve and triage scoring mode. However, all doses were satisfactory at 4 Gy. Six laboratories had estimated doses within 95% uncertainty limits at 0 Gy, seven at 1.5 Gy, and four at 4 Gy. While the mean dose for sample C was significantly biased using robust algorithms, applying weights to compensate for the laboratory's analysis expertise reduced the bias by half. The bias from delivered doses was only notable for sample C. Using the common calibration curve for dose estimation reduced the standard deviation (s*) estimated by robust methods for all three samples. CONCLUSIONS The results underscore the significance of performing interlaboratory comparison exercises that involve digitized and electronically transmitted images, even when analyzing non-irradiated samples. In situations where the participating laboratories possess different levels of proficiency, it may prove essential to employ weighted robust algorithms to achieve precise outcomes.
Collapse
Affiliation(s)
| | - Diego Alem Glison
- Genetics Department and Biodosimetry Service, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay
| | | | | | | | | | - Valentina Verdejo
- Cytogenetic Dosimetry Laboratory, Chilean Nuclear Energy Commission (CCHEN), Santiago, Chile
| | - Marina Di Giorgio
- Biological Dosimetry Laboratory, Nuclear Regulatory Authority (ARN), Buenos Aires, Argentina
| | - Analía Radl
- Biological Dosimetry Laboratory, Nuclear Regulatory Authority (ARN), Buenos Aires, Argentina
| | - María Rosa Taja
- Biological Dosimetry Laboratory, Nuclear Regulatory Authority (ARN), Buenos Aires, Argentina
| | - Mayra Deminge
- Biological Dosimetry Laboratory, Nuclear Regulatory Authority (ARN), Buenos Aires, Argentina
| | - Ana Rada-Tarifa
- Unidad de Citogenética - Instituto de Genética, Facultad de Medicina, Universidad Mayor de San Andrés, La Paz, Bolivia
| | - Erika Lafuente-Alvarez
- Unidad de Citogenética - Instituto de Genética, Facultad de Medicina, Universidad Mayor de San Andrés, La Paz, Bolivia
| | - Fabiana Farias de Lima
- Biological Dosimetry Laboratory, Northeast Regional Center for Nuclear Sciences CRCN-NE/CNEN, Rio de Janeiro, Brazil
| | - Suy Hwang
- Biological Dosimetry Laboratory, Northeast Regional Center for Nuclear Sciences CRCN-NE/CNEN, Rio de Janeiro, Brazil
| | - Mariana Esposito Mendes
- Biological Dosimetry Laboratory, Northeast Regional Center for Nuclear Sciences CRCN-NE/CNEN, Rio de Janeiro, Brazil
| | - Tania Mandina-Cardoso
- Radiobiology Laboratory, Center for Radiation Protection and Hygiene (CPHR), La Habana, Cuba
| | | | | | | | - Norma Monjagata
- Instituto de Investigaciones en Ciencias de la Salud, Asunción, Paraguay
| | | | - Marco Espinoza-Zevallos
- Cytogenetics and Radiobiology Laboratory, Directorate of Services, Peruvian Institute of Nuclear Energy, San Borja, Peru
| | - Aida Falcon de Vargas
- Vargas Hospital of Caracas. Hospital de Clínicas Caracas. Central University of Venezuela, Caracas, Venezuela
| | - Maria Vittoria Di Tomaso
- Genetics Department and Biodosimetry Service, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay
| | - Bret Holladay
- Statistics Department, California Polytechnic State University, San Luis Obispo, CA, USA
| | - Omar García Lima
- Radiobiology Laboratory, Center for Radiation Protection and Hygiene (CPHR), La Habana, Cuba
| | - Wilner Martínez-López
- Genetics Department and Biodosimetry Service, Instituto de Investigaciones Biológicas Clemente Estable, Montevideo, Uruguay
| |
Collapse
|
2
|
Meher PK, Lundholm L, Wojcik A. Fluorescence in situ hybridisation for interphase chromosomal aberration-based biological dosimetry. RADIATION PROTECTION DOSIMETRY 2023; 199:1501-1507. [PMID: 37721087 PMCID: PMC10505941 DOI: 10.1093/rpd/ncac264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 09/30/2022] [Accepted: 11/16/2022] [Indexed: 09/19/2023]
Abstract
Metaphase spreads stained with Giemsa or painted with chromosome-specific probes by fluorescence in situ hybridisation (FISH) have been in use since long for retrospective dose assessment (biological dosimetry). However, in cases of accidental exposure to ionising radiation, the culturing of lymphocytes to obtain metaphase chromosomes and analysis of chromosomal aberrations is time-consuming and problematic after high radiation doses. Similarly, analysing chromosomal damage in G0/G1 cells or nondividing cells by premature chromosome condensation is laborious. Following large-scale radiological emergencies, the time required for analysis is more important than precision of dose estimate. Painting of whole chromosomes using chromosome-specific probes in interphase nuclei by the FISH technique will eliminate the time required for cell culture and allow a fast dose estimate, provided that a meaningful dose-response can be obtained by scoring the number of chromosomal domains visible in interphase nuclei. In order to test the applicability of interphase FISH for quick biological dosimetry, whole blood from a healthy donor was irradiated with 8 Gy of gamma radiation. Irradiated whole blood was kept for 2 h at 37°C to allow DNA repair and thereafter processed for FISH with probes specific for Chromosomes-1 and 2. Damaged chromosomal fragments, distinguished by extra color domains, were observed in interphase nuclei of lymphocytes irradiated with 8 Gy. These fragments were efficiently detected and quantified by the FISH technique utilising both confocal and single plane fluorescence microscopy. Furthermore, a clear dose-response curve for interphase fragments was achieved following exposure to 0, 1, 2, 4 and 8 Gy of gamma radiation. These results demonstrate interphase FISH as a promising test for biodosimetry and for studying cytogenetic effects of radiation in nondividing cells.
Collapse
Affiliation(s)
- Prabodha Kumar Meher
- Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
| | - Lovisa Lundholm
- Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
| | - Andrzej Wojcik
- Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
- Institute of Biology, Jan Kochanowski University, Kielce, Poland
| |
Collapse
|
3
|
Port M, Barquinero JF, Endesfelder D, Moquet J, Oestreicher U, Terzoudi G, Trompier F, Vral A, Abe Y, Ainsbury L, Alkebsi L, Amundson S, Badie C, Baeyens A, Balajee A, Balázs K, Barnard S, Bassinet C, Beaton-Green L, Beinke C, Bobyk L, Brochard P, Brzoska K, Bucher M, Ciesielski B, Cuceu C, Discher M, D,Oca M, Domínguez I, Doucha-Senf S, Dumitrescu A, Duy P, Finot F, Garty G, Ghandhi S, Gregoire E, Goh V, Güçlü I, Hadjiiska L, Hargitai R, Hristova R, Ishii K, Kis E, Juniewicz M, Kriehuber R, Lacombe J, Lee Y, Lopez Riego M, Lumniczky K, Mai T, Maltar-Strmečki N, Marrale M, Martinez J, Marciniak A, Maznyk N, McKeever S, Meher P, Milanova M, Miura T, Gil OM, Montoro A, Domene MM, Mrozik A, Nakayama R, O’Brien G, Oskamp D, Ostheim P, Pajic J, Pastor N, Patrono C, Pujol-Canadell M, Rodriguez MP, Repin M, Romanyukha A, Rößler U, Sabatier L, Sakai A, Scherthan H, Schüle S, Seong K, Sevriukova O, Sholom S, Sommer S, Suto Y, Sypko T, Szatmári T, Takahashi-Sugai M, Takebayashi K, Testa A, Testard I, Tichy A, Triantopoulou S, Tsuyama N, Unverricht-Yeboah M, Valente M, Van Hoey O, Wilkins R, Wojcik A, Wojewodzka M, Younghyun L, Zafiropoulos D, Abend M. RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays. Radiat Res 2023; 199:535-555. [PMID: 37310880 PMCID: PMC10508307 DOI: 10.1667/rade-22-00207.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Accepted: 01/10/2023] [Indexed: 06/15/2023]
Abstract
Tools for radiation exposure reconstruction are required to support the medical management of radiation victims in radiological or nuclear incidents. Different biological and physical dosimetry assays can be used for various exposure scenarios to estimate the dose of ionizing radiation a person has absorbed. Regular validation of the techniques through inter-laboratory comparisons (ILC) is essential to guarantee high quality results. In the current RENEB inter-laboratory comparison, the performance quality of established cytogenetic assays [dicentric chromosome assay (DCA), cytokinesis-block micronucleus assay (CBMN), stable chromosomal translocation assay (FISH) and premature chromosome condensation assay (PCC)] was tested in comparison to molecular biological assays [gamma-H2AX foci (gH2AX), gene expression (GE)] and physical dosimetry-based assays [electron paramagnetic resonance (EPR), optically or thermally stimulated luminescence (LUM)]. Three blinded coded samples (e.g., blood, enamel or mobiles) were exposed to 0, 1.2 or 3.5 Gy X-ray reference doses (240 kVp, 1 Gy/min). These doses roughly correspond to clinically relevant groups of unexposed to low exposed (0-1 Gy), moderately exposed (1-2 Gy, no severe acute health effects expected) and highly exposed individuals (>2 Gy, requiring early intensive medical care). In the frame of the current RENEB inter-laboratory comparison, samples were sent to 86 specialized teams in 46 organizations from 27 nations for dose estimation and identification of three clinically relevant groups. The time for sending early crude reports and more precise reports was documented for each laboratory and assay where possible. The quality of dose estimates was analyzed with three different levels of granularity, 1. by calculating the frequency of correctly reported clinically relevant dose categories, 2. by determining the number of dose estimates within the uncertainty intervals recommended for triage dosimetry (±0.5 Gy or ±1.0 Gy for doses <2.5 Gy or >2.5 Gy), and 3. by calculating the absolute difference (AD) of estimated doses relative to the reference doses. In total, 554 dose estimates were submitted within the 6-week period given before the exercise was closed. For samples processed with the highest priority, earliest dose estimates/categories were reported within 5-10 h of receipt for GE, gH2AX, LUM, EPR, 2-3 days for DCA, CBMN and within 6-7 days for the FISH assay. For the unirradiated control sample, the categorization in the correct clinically relevant group (0-1 Gy) as well as the allocation to the triage uncertainty interval was, with the exception of a few outliers, successfully performed for all assays. For the 3.5 Gy sample the percentage of correct classifications to the clinically relevant group (≥2 Gy) was between 89-100% for all assays, with the exception of gH2AX. For the 1.2 Gy sample, an exact allocation to the clinically relevant group was more difficult and 0-50% or 0-48% of the estimates were wrongly classified into the lowest or highest dose categories, respectively. For the irradiated samples, the correct allocation to the triage uncertainty intervals varied considerably between assays for the 1.2 Gy (29-76%) and 3.5 Gy (17-100%) samples. While a systematic shift towards higher doses was observed for the cytogenetic-based assays, extreme outliers exceeding the reference doses 2-6 fold were observed for EPR, FISH and GE assays. These outliers were related to a particular material examined (tooth enamel for EPR assay, reported as kerma in enamel, but when converted into the proper quantity, i.e. to kerma in air, expected dose estimates could be recalculated in most cases), the level of experience of the teams (FISH) and methodological uncertainties (GE). This was the first RENEB ILC where everything, from blood sampling to irradiation and shipment of the samples, was organized and realized at the same institution, for several biological and physical retrospective dosimetry assays. Almost all assays appeared comparably applicable for the identification of unexposed and highly exposed individuals and the allocation of medical relevant groups, with the latter requiring medical support for the acute radiation scenario simulated in this exercise. However, extreme outliers or a systematic shift of dose estimates have been observed for some assays. Possible reasons will be discussed in the assay specific papers of this special issue. In summary, this ILC clearly demonstrates the need to conduct regular exercises to identify research needs, but also to identify technical problems and to optimize the design of future ILCs.
Collapse
Affiliation(s)
- M. Port
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | | | | | - J. Moquet
- UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom
| | | | - G. Terzoudi
- National Centre for Scientific Research “Demokritos”, Health Physics, Radiobiology & Cytogenetics Laboratory, Agia Paraskevi, Greece
| | - F. Trompier
- Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France
| | - A. Vral
- Ghent University, Radiobiology Research Unit, Gent, Belgium
| | - Y. Abe
- Department of Radiation Biology and Protection, Nagasaki University, Japan
| | - L. Ainsbury
- UK Health Security Agency and Office for Health Improvement and Disparities, Cytogenetics and Pathology Group, Oxfordshire, England
| | - L Alkebsi
- Department of Radiation Measurement and Dose Assessment, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan
| | - S.A. Amundson
- Columbia University, Irving Medical Center, Center for Radiological Research, New York, New York
| | - C. Badie
- UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom
| | - A. Baeyens
- Ghent University, Radiobiology Research Unit, Gent, Belgium
| | - A.S. Balajee
- Cytogenetic Biodosimetry Laboratory, Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee
| | - K. Balázs
- Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - S. Barnard
- UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom
| | - C. Bassinet
- Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France
| | | | - C. Beinke
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - L. Bobyk
- Institut de Recherche Biomédicale des Armées (IRBA), Bretigny Sur Orge, France
| | | | - K. Brzoska
- Institute of Nuclear Chemistry and Technology, Warsaw, Poland
| | - M. Bucher
- Bundesamt für Strahlenschutz, Oberschleißheim, Germany
| | - B. Ciesielski
- Medical University of Gdansk, Department of Physics and Biophysics, Gdansk, Poland
| | - C. Cuceu
- Genevolution, Porcheville, France
| | - M. Discher
- Paris-Lodron-University of Salzburg, Department of Environment and Biodiversity, 5020 Salzburg, Austria
| | - M.C. D,Oca
- Università Degli Studi di Palermo, Dipartimento di Fisica e Chimica “Emilio Segrè,” Palermo, Italy
| | - I. Domínguez
- Universidad de Sevilla, Departamento de Biología Celular, Sevilla, Spain
| | | | - A. Dumitrescu
- National Institute of Public Health, Radiation Hygiene Laboratory, Bucharest, Romania
| | - P.N. Duy
- Dalat Nuclear Research Institute, Radiation Technlogy & Biotechnology Center, Dalat City, Vietnam
| | - F. Finot
- Genevolution, Porcheville, France
| | - G. Garty
- Columbia University, Irving Medical Center, Center for Radiological Research, New York, New York
| | - S.A. Ghandhi
- Columbia University, Irving Medical Center, Center for Radiological Research, New York, New York
| | - E. Gregoire
- Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France
| | - V.S.T. Goh
- Department of Radiobiology, Singapore Nuclear Research and Safety Initiative (SNRSI), National University of Singapore, Singapore
| | - I. Güçlü
- TENMAK, Nuclear Energy Research Institute, Technology Development and Nuclear Research Department, Türkey
| | - L. Hadjiiska
- National Centre of Radiobiology and Radiation Protection, Sofia, Bulgaria
| | - R. Hargitai
- Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - R. Hristova
- National Centre of Radiobiology and Radiation Protection, Sofia, Bulgaria
| | - K. Ishii
- Department of Radiation Measurement and Dose Assessment, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan
| | - E. Kis
- Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - M. Juniewicz
- Medical University of Gdansk, Department of Physics and Biophysics, Gdansk, Poland
| | - R. Kriehuber
- Department of Safety and Radiation Protection, Forschungszentrum Jülich, Jülich, Germany
| | - J. Lacombe
- University of Arizona, Center for Applied Nanobioscience & Medicine, Phoenix, Arizona
| | - Y. Lee
- Laboratory of Biological Dosimetry, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | | | - K. Lumniczky
- Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - T.T. Mai
- Dalat Nuclear Research Institute, Radiation Technlogy & Biotechnology Center, Dalat City, Vietnam
| | - N. Maltar-Strmečki
- Ruðer Boškovic Institute, Division of Physical Chemistry, Zagreb, Croatia
| | - M. Marrale
- Università Degli Studi di Palermo, Dipartimento di Fisica e Chimica “Emilio Segrè,” Palermo, Italy
| | - J.S. Martinez
- Institut de Radioprotection et de Surete Nucleaire, Fontenay aux Roses, France
| | - A. Marciniak
- Medical University of Gdansk, Department of Physics and Biophysics, Gdansk, Poland
| | - N. Maznyk
- Radiation Cytogenetics Laboratory, S.P. Grigoriev Institute for Medical Radiology and Oncology of Ukrainian National Academy of Medical Science, Kharkiv, Ukraine
| | - S.W.S. McKeever
- Radiation Dosimetry Laboratory, Oklahoma State University, Stillwater, Oklahoma
| | | | - M. Milanova
- University of Defense, Faculty of Military Health Sciences, Hradec Králové, Czech Republic
| | - T. Miura
- Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
| | - O. Monteiro Gil
- Instituto Superior Técnico/ Campus Tecnológico e Nuclear, Lisbon, Portugal
| | - A. Montoro
- Servicio de Protección Radiológica. Laboratorio de Dosimetría Biológica, Valencia, Spain
| | - M. Moreno Domene
- Hospital General Universitario Gregorio Marañón, Laboratorio de dosimetría biológica, Madrid, Spain
| | - A. Mrozik
- Institute of Nuclear Physics, Polish Academy of Sciences, Krakow, Poland
| | - R. Nakayama
- Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
| | - G. O’Brien
- UK Health Security Agency, Radiation, Chemical and Environmental Hazards Division, Oxfordshire, United Kingdom
| | - D. Oskamp
- Department of Safety and Radiation Protection, Forschungszentrum Jülich, Jülich, Germany
| | - P. Ostheim
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - J. Pajic
- Serbian Institute of Occupational Health, Belgrade, Serbia
| | - N. Pastor
- Universidad de Sevilla, Departamento de Biología Celular, Sevilla, Spain
| | - C. Patrono
- Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Rome, Italy
| | | | - M.J. Prieto Rodriguez
- Hospital General Universitario Gregorio Marañón, Laboratorio de dosimetría biológica, Madrid, Spain
| | - M. Repin
- Columbia University, Irving Medical Center, Center for Radiological Research, New York, New York
| | | | - U. Rößler
- Bundesamt für Strahlenschutz, Oberschleißheim, Germany
| | | | - A. Sakai
- Department of Radiation Life Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan
| | - H. Scherthan
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - S. Schüle
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - K.M. Seong
- Laboratory of Biological Dosimetry, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | | | - S. Sholom
- Radiation Dosimetry Laboratory, Oklahoma State University, Stillwater, Oklahoma
| | - S. Sommer
- Institute of Nuclear Chemistry and Technology, Warsaw, Poland
| | - Y. Suto
- Department of Radiation Measurement and Dose Assessment, National Institute of Radiological Sciences, National Institutes for Quantum Science and Technology, Chiba, Japan
| | - T. Sypko
- Radiation Cytogenetics Laboratory, S.P. Grigoriev Institute for Medical Radiology and Oncology of Ukrainian National Academy of Medical Science, Kharkiv, Ukraine
| | - T. Szatmári
- Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - M. Takahashi-Sugai
- Department of Radiation Life Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan
| | - K. Takebayashi
- Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
| | - A. Testa
- Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Rome, Italy
| | - I. Testard
- CEA-Saclay, Gif-sur-Yvette Cedex, France
| | - A. Tichy
- University of Defense, Faculty of Military Health Sciences, Hradec Králové, Czech Republic
| | - S. Triantopoulou
- National Centre for Scientific Research “Demokritos”, Health Physics, Radiobiology & Cytogenetics Laboratory, Agia Paraskevi, Greece
| | - N. Tsuyama
- Department of Radiation Life Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan
| | - M. Unverricht-Yeboah
- Department of Safety and Radiation Protection, Forschungszentrum Jülich, Jülich, Germany
| | - M. Valente
- CEA-Saclay, Gif-sur-Yvette Cedex, France
| | - O. Van Hoey
- Belgian Nuclear Research Center SCK CEN, Mol, Belgium
| | | | - A. Wojcik
- Stockholm University, Stockholm, Sweden
| | - M. Wojewodzka
- Institute of Nuclear Chemistry and Technology, Warsaw, Poland
| | - Lee Younghyun
- Laboratory of Biological Dosimetry, Korea Institute of Radiological & Medical Sciences, Seoul, Republic of Korea
| | - D. Zafiropoulos
- Laboratori Nazionali di Legnaro - Istituto Nazionale di Fisica Nucleare, Legnaro, Italy
| | - M. Abend
- Bundeswehr Institute of Radiobiology, Munich, Germany
| |
Collapse
|
4
|
Abend M, Amundson S, Badie C, Brzoska K, Kriehuber R, Lacombe J, Lopez-Riego M, Lumniczky K, Endesfelder D, O’Brien G, Doucha-Senf S, Ghandhi S, Hargitai R, Kis E, Lundholm L, Oskamp D, Ostheim P, Schüle S, Schwanke D, Shuryak I, Siebenwith C, Unverricht-Yeboah M, Wojcik A, Yang J, Zenhausern F, Port M. RENEB Inter-Laboratory Comparison 2021: The Gene Expression Assay. Radiat Res 2023; 199:598-615. [PMID: 37057982 PMCID: PMC11106736 DOI: 10.1667/rade-22-00206.1] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 01/24/2023] [Indexed: 04/15/2023]
Abstract
Early and high-throughput individual dose estimates are essential following large-scale radiation exposure events. In the context of the Running the European Network for Biodosimetry and Physical Dosimetry (RENEB) 2021 exercise, gene expression assays were conducted and their corresponding performance for dose-assessment is presented in this publication. Three blinded, coded whole blood samples from healthy donors were exposed to 0, 1.2 and 3.5 Gy X-ray doses (240 kVp, 1 Gy/min) using the X-ray source Yxlon. These exposures correspond to clinically relevant groups of unexposed, low dose (no severe acute health effects expected) and high dose exposed individuals (requiring early intensive medical health care). Samples were sent to eight teams for dose estimation and identification of clinically relevant groups. For quantitative reverse transcription polymerase chain reaction (qRT-PCR) and microarray analyses, samples were lysed, stored at 20°C and shipped on wet ice. RNA isolations and assays were run in each laboratory according to locally established protocols. The time-to-result for both rough early and more precise later reports has been documented where possible. Accuracy of dose estimates was calculated as the difference between estimated and reference doses for all doses (summed absolute difference, SAD) and by determining the number of correctly reported dose estimates that were defined as ±0.5 Gy for reference doses <2.5 Gy and ±1.0 Gy for reference doses >3 Gy, as recommended for triage dosimetry. We also examined the allocation of dose estimates to clinically/diagnostically relevant exposure groups. Altogether, 105 dose estimates were reported by the eight teams, and the earliest report times on dose categories and estimates were 5 h and 9 h, respectively. The coefficient of variation for 85% of all 436 qRT-PCR measurements did not exceed 10%. One team reported dose estimates that systematically deviated several-fold from reported dose estimates, and these outliers were excluded from further analysis. Teams employing a combination of several genes generated about two-times lower median SADs (0.8 Gy) compared to dose estimates based on single genes only (1.7 Gy). When considering the uncertainty intervals for triage dosimetry, dose estimates of all teams together were correctly reported in 100% of the 0 Gy, 50% of the 1.2 Gy and 50% of the 3.5 Gy exposed samples. The order of dose estimates (from lowest to highest) corresponding to three dose categories (unexposed, low dose and highest exposure) were correctly reported by all teams and all chosen genes or gene combinations. Furthermore, if teams reported no exposure or an exposure >3.5 Gy, it was always correctly allocated to the unexposed and the highly exposed group, while low exposed (1.2 Gy) samples sometimes could not be discriminated from highly (3.5 Gy) exposed samples. All teams used FDXR and 78.1% of correct dose estimates used FDXR as one of the predictors. Still, the accuracy of reported dose estimates based on FDXR differed considerably among teams with one team's SAD (0.5 Gy) being comparable to the dose accuracy employing a combination of genes. Using the workflow of this reference team, we performed additional experiments after the exercise on residual RNA and cDNA sent by six teams to the reference team. All samples were processed similarly with the intention to improve the accuracy of dose estimates when employing the same workflow. Re-evaluated dose estimates improved for half of the samples and worsened for the others. In conclusion, this inter-laboratory comparison exercise enabled (1) identification of technical problems and corrections in preparations for future events, (2) confirmed the early and high-throughput capabilities of gene expression, (3) emphasized different biodosimetry approaches using either only FDXR or a gene combination, (4) indicated some improvements in dose estimation with FDXR when employing a similar methodology, which requires further research for the final conclusion and (5) underlined the applicability of gene expression for identification of unexposed and highly exposed samples, supporting medical management in radiological or nuclear scenarios.
Collapse
Affiliation(s)
- M. Abend
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - S.A. Amundson
- Columbia University Irving Medical Center, Center for Radiological Research, New York, New York
| | - C. Badie
- UK Health Security Agency and Office for Health Improvement and Disparities, Centre for Radiation, Chemical and Environmental Hazards, Oxfordshire, England
| | - K. Brzoska
- Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Warsaw, Poland
| | - R. Kriehuber
- Forschungszentrum Jülich, Department of Safety and Radiation Protection, Jülich, Germany
| | - J. Lacombe
- University of Arizona, Center for Applied Nanobioscience & Medicine, Phoenix, Arizona
| | - M. Lopez-Riego
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
| | - K. Lumniczky
- Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - D. Endesfelder
- Bundesamt für Strahlenschutz, BfS, Oberschleißheim, Germany
| | - G. O’Brien
- UK Health Security Agency and Office for Health Improvement and Disparities, Centre for Radiation, Chemical and Environmental Hazards, Oxfordshire, England
| | | | - S.A. Ghandhi
- Columbia University Irving Medical Center, Center for Radiological Research, New York, New York
| | - R. Hargitai
- Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - E. Kis
- Radiation Medicine Unit, Department of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - L. Lundholm
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
| | - D. Oskamp
- Forschungszentrum Jülich, Department of Safety and Radiation Protection, Jülich, Germany
| | - P. Ostheim
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - S. Schüle
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - D. Schwanke
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - I. Shuryak
- Columbia University Irving Medical Center, Center for Radiological Research, New York, New York
| | - C. Siebenwith
- Bundeswehr Institute of Radiobiology, Munich, Germany
| | - M. Unverricht-Yeboah
- Forschungszentrum Jülich, Department of Safety and Radiation Protection, Jülich, Germany
| | - A. Wojcik
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
| | - J. Yang
- University of Arizona, Center for Applied Nanobioscience & Medicine, Phoenix, Arizona
| | - F. Zenhausern
- University of Arizona, Center for Applied Nanobioscience & Medicine, Phoenix, Arizona
| | - M. Port
- Bundeswehr Institute of Radiobiology, Munich, Germany
| |
Collapse
|
5
|
Chaurasia RK, Shirsath KB, Sapra BK. Protocol for one-step selective lysis of red blood cells and platelets with long-term preservation of white blood cells (human) at ambient temperature. STAR Protoc 2021; 2:100834. [PMID: 34568847 PMCID: PMC8449125 DOI: 10.1016/j.xpro.2021.100834] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Current protocols for storage of white blood cells (WBCs) rely on constant refrigeration. The protocol described below explains the preparation of a fixative combination saline (FCS) formulation, which allows fixation of human WBCs and lysis of red blood cells and platelets (at ambient temperature, 4–35oC) in whole blood samples in one step. FCS can be used for storing and transporting blood at ambient temperatures for up to 4 months, without altering the nuclear morphology and genomic integrity of WBCs. FCS for single-step preparation of human WBCs FCS fixes and preserves WBCs; FCS selectively lyses RBCs and platelets Fixed WBCs can be stored and transported at ambient temperature up to 4 months FCS can overcome the constraint of refrigeration of blood samples
Collapse
Affiliation(s)
- Rajesh K Chaurasia
- Radiological Physics and Advisory Division, Bhabha Atomic Research Centre (BARC), Mumbai, Maharashtra 400094, India.,Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra 400094, India
| | - Kapil B Shirsath
- Radiological Physics and Advisory Division, Bhabha Atomic Research Centre (BARC), Mumbai, Maharashtra 400094, India
| | - Balvinder K Sapra
- Radiological Physics and Advisory Division, Bhabha Atomic Research Centre (BARC), Mumbai, Maharashtra 400094, India.,Homi Bhabha National Institute (HBNI), Mumbai, Maharashtra 400094, India
| |
Collapse
|
6
|
Ainsbury EA, Moquet J, Sun M, Barnard S, Ellender M, Lloyd D. The future of biological dosimetry in mass casualty radiation emergency response, personalized radiation risk estimation and space radiation protection. Int J Radiat Biol 2021; 98:421-427. [PMID: 34515621 DOI: 10.1080/09553002.2021.1980629] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
PURPOSE The aim of this brief personal, high level review is to consider the state of the art for biological dosimetry for radiation routine and emergency response, and the potential future progress in this fascinating and active field. Four areas in which biomarkers may contribute to scientific advancement through improved dose and exposure characterization, as well as potential contributions to personalized risk estimation, are considered: emergency dosimetry, molecular epidemiology, personalized medical dosimetry, and space travel. CONCLUSION Ionizing radiation biodosimetry is an exciting field which will continue to benefit from active networking and collaboration with the wider fields of radiation research and radiation emergency response to ensure effective, joined up approaches to triage; radiation epidemiology to assess long term, low dose, radiation risk; radiation protection of workers, optimization and justification of radiation for diagnosis or treatment of patients in clinical uses, and protection of individuals traveling to space.
Collapse
Affiliation(s)
- Elizabeth A Ainsbury
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, UK.,Environmental Research Group within the School of Public Health, Faculty of Medicine at Imperial College of Science, Technology and Medicine, London, UK
| | - Jayne Moquet
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, UK
| | - Mingzhu Sun
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, UK
| | - Stephen Barnard
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, UK
| | - Michele Ellender
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, UK
| | - David Lloyd
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, UK
| |
Collapse
|
7
|
Herate C, Sabatier L. Retrospective biodosimetry techniques: Focus on cytogenetics assays for individuals exposed to ionizing radiation. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 2020; 783:108287. [PMID: 32192645 DOI: 10.1016/j.mrrev.2019.108287] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2019] [Revised: 09/26/2019] [Accepted: 11/01/2019] [Indexed: 01/28/2023]
Abstract
In the absence of physical data, biodosimetry tools are required for fast dose and risk assessment in the event of radiological or nuclear mass accidents or attacks to triage exposed humans and take immediate medical countermeasures. Biodosimetry tools have mostly been developed for retrospective dose assessment and the follow-up of victims of irradiation. Among them, cytogenetics analyses, to reveal chromosome damage, are the most developed and allow the determination of doses from blood samples as low as 100 mGy. Various cytogenetic tests have already allowed retrospective dose assessment of Chernobyl liquidators and military personnel exposed to nuclear tests after decades. In this review, we discuss the properties of various biodosimetry techniques, such as their sensitivity and limitations as a function of the time from exposure, using multiple examples of nuclear catastrophes or working exposure. Among them, chromosome FISH hybridization, which reveals chromosome translocations, is the most reliable due to the persistence of translocations for decades, whereas dicentric chromosome and micronuclei assays allow rapid and accurate dose assessment a short time after exposure. Both need to be adjusted through mathematical algorithms for retrospective analyses, accounting for the time since exposure and the victims' age. The goal for the future will be to better model chromosome damage, reduce the time to result, and develop new complementary biodosimetry approaches, such as mutation signatures.
Collapse
Affiliation(s)
- C Herate
- PROCyTox, French Alternative Energies and Atomic Energy Commission (CEA), University Paris-Saclay, Fontenay-aux-Roses, France
| | - L Sabatier
- PROCyTox, French Alternative Energies and Atomic Energy Commission (CEA), University Paris-Saclay, Fontenay-aux-Roses, France.
| |
Collapse
|
8
|
Shuryak I, Turner HC, Perrier JR, Cunha L, Canadell MP, Durrani MH, Harken A, Bertucci A, Taveras M, Garty G, Brenner DJ. A High Throughput Approach to Reconstruct Partial-Body and Neutron Radiation Exposures on an Individual Basis. Sci Rep 2020; 10:2899. [PMID: 32076014 PMCID: PMC7031285 DOI: 10.1038/s41598-020-59695-9] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2019] [Accepted: 01/27/2020] [Indexed: 11/28/2022] Open
Abstract
Biodosimetry-based individualized reconstruction of complex irradiation scenarios (partial-body shielding and/or neutron + photon mixtures) can improve treatment decisions after mass-casualty radiation-related incidents. We used a high-throughput micronucleus assay with automated scanning and imaging software on ex-vivo irradiated human lymphocytes to: a) reconstruct partial-body and/or neutron exposure, and b) estimate separately the photon and neutron doses in a mixed exposure. The mechanistic background is that, compared with total-body photon irradiations, neutrons produce more heavily-damaged lymphocytes with multiple micronuclei/binucleated cell, whereas partial-body exposures produce fewer such lymphocytes. To utilize these differences for biodosimetry, we developed metrics that describe micronuclei distributions in binucleated cells and serve as predictors in machine learning or parametric analyses of the following scenarios: (A) Homogeneous gamma-irradiation, mimicking total-body exposures, vs. mixtures of irradiated blood with unirradiated blood, mimicking partial-body exposures. (B) X rays vs. various neutron + photon mixtures. The results showed high accuracies of scenario and dose reconstructions. Specifically, receiver operating characteristic curve areas (AUC) for sample classification by exposure type reached 0.931 and 0.916 in scenarios A and B, respectively. R2 for actual vs. reconstructed doses in these scenarios reached 0.87 and 0.77, respectively. These encouraging findings demonstrate a proof-of-principle for the proposed approach of high-throughput reconstruction of clinically-relevant complex radiation exposure scenarios.
Collapse
Affiliation(s)
- Igor Shuryak
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA.
| | - Helen C Turner
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - Jay R Perrier
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - Lydia Cunha
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - Monica Pujol Canadell
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - Mohammad H Durrani
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - Andrew Harken
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - Antonella Bertucci
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - Maria Taveras
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - Guy Garty
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| | - David J Brenner
- Center for Radiological Research, Columbia University Irving Medical Center, New York, NY, USA
| |
Collapse
|
9
|
Hargitai R, Roivainen P, Kis D, Luukkonen J, Sáfrány G, Seppälä J, Szatmári T, Virén T, Vuolukka K, Salomaa S, Lumniczky K. Mitochondrial DNA damage in the hair bulb: can it be used as a noninvasive biomarker of local exposure to low LET ionizing radiation? Int J Radiat Biol 2019; 96:491-501. [PMID: 31846382 DOI: 10.1080/09553002.2020.1704910] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Purpose: Our aim was to evaluate whether mitochondrial DNA (mtDNA) damage in hair bulbs could be a suitable biomarker for the detection of local exposure to ionizing radiation.Materials and methods: Mouse hair was collected 4 and 24 hours, 3 and 10 days after single whole-body exposure to 0, 0.1, and 2 Gy radiation. Pubic hair (treated area) and scalp hair (control area) were collected from 13 prostate cancer patients before and after fractioned radiotherapy with an average total dose of 2.7 Gy to follicles after five fractions. Unspecified lesion frequency of mtDNA was analyzed with long PCR, large mtDNA deletion levels were tested with real-time PCR.Results: Unspecified lesion frequency of mtDNA significantly increased in mouse hair 24 hours after irradiation with 2 Gy, but variance among samples was high. No increase in lesion frequency could be detected after 0.1 Gy irradiation. In prostate cancer patients, there was no significant change in either the unspecified lesion frequency or in the proportion of 4934-bp deleted mtDNA in pubic hair after radiotherapy. The proportions of murine 3860-bp common deletion, human 4977-bp common deletion and 7455-bp deleted mtDNA were too low to be analyzed reliably.Conclusions: Our results suggest that the unspecified lesion frequency and proportion of large deletions of mtDNA in hair bulbs are not suitable biomarkers of exposure to ionizing radiation.
Collapse
Affiliation(s)
- Rita Hargitai
- Department of Radiation Medicine, Division of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - Päivi Roivainen
- Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finland
| | - Dávid Kis
- Department of Radiation Medicine, Division of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - Jukka Luukkonen
- Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finland
| | - Géza Sáfrány
- Department of Radiation Medicine, Division of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - Jan Seppälä
- Center of Oncology, Kuopio University Hospital, Kuopio, Finland
| | - Tünde Szatmári
- Department of Radiation Medicine, Division of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| | - Tuomas Virén
- Center of Oncology, Kuopio University Hospital, Kuopio, Finland
| | | | - Sisko Salomaa
- Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finland
| | - Katalin Lumniczky
- Department of Radiation Medicine, Division of Radiobiology and Radiohygiene, National Public Health Centre, Budapest, Hungary
| |
Collapse
|
10
|
Goh VST, Fujishima Y, Abe Y, Sakai A, Yoshida MA, Ariyoshi K, Kasai K, Wilkins RC, Blakely WF, Miura T. Construction of fluorescence in situ hybridization (FISH) translocation dose-response calibration curve with multiple donor data sets using R, based on ISO 20046:2019 recommendations. Int J Radiat Biol 2019; 95:1668-1684. [DOI: 10.1080/09553002.2019.1664788] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- Valerie Swee Ting Goh
- Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
| | - Yohei Fujishima
- Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
- Department of Radiation Biology, Tohoku University School of Medicine, Sendai, Japan
| | - Yu Abe
- Department of Radiation Life Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan
| | - Akira Sakai
- Department of Radiation Life Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan
| | - Mitsuaki A. Yoshida
- Department of Radiation Biology, Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
| | - Kentaro Ariyoshi
- Department of Radiation Biology, Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
| | - Kosuke Kasai
- Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
| | - Ruth C. Wilkins
- Consumer and Clinical Radiation Protection Bureau, Healthy Environments and Consumer Safety Branch, Ottawa, ON, Canada
| | - William F. Blakely
- Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
| | - Tomisato Miura
- Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
- Department of Radiation Biology, Institute of Radiation Emergency Medicine, Hirosaki University, Hirosaki, Japan
| |
Collapse
|
11
|
Ainsbury EA, Samaga D, Della Monaca S, Marrale M, Bassinet C, Burbidge CI, Correcher V, Discher M, Eakins J, Fattibene P, Güçlü I, Higueras M, Lund E, Maltar-Strmecki N, McKeever S, Rääf CL, Sholom S, Veronese I, Wieser A, Woda C, Trompier F. UNCERTAINTY ON RADIATION DOSES ESTIMATED BY BIOLOGICAL AND RETROSPECTIVE PHYSICAL METHODS. RADIATION PROTECTION DOSIMETRY 2018; 178:382-404. [PMID: 28981844 DOI: 10.1093/rpd/ncx125] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/23/2017] [Accepted: 08/09/2017] [Indexed: 05/16/2023]
Abstract
Biological and physical retrospective dosimetry are recognised as key techniques to provide individual estimates of dose following unplanned exposures to ionising radiation. Whilst there has been a relatively large amount of recent development in the biological and physical procedures, development of statistical analysis techniques has failed to keep pace. The aim of this paper is to review the current state of the art in uncertainty analysis techniques across the 'EURADOS Working Group 10-Retrospective dosimetry' members, to give concrete examples of implementation of the techniques recommended in the international standards, and to further promote the use of Monte Carlo techniques to support characterisation of uncertainties. It is concluded that sufficient techniques are available and in use by most laboratories for acute, whole body exposures to highly penetrating radiation, but further work will be required to ensure that statistical analysis is always wholly sufficient for the more complex exposure scenarios.
Collapse
Affiliation(s)
- Elizabeth A Ainsbury
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxford OX11 ORQ, UK
| | - Daniel Samaga
- Bundesamt für Strahlenschutz, Ingolstaedter Landstr. 1, 85764 Oberschleissheim, Germany
| | - Sara Della Monaca
- Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
| | - Maurizio Marrale
- Department of Physics and Chemistry and Advanced Technologies Network Center, University of Palermo, Viale delle Scienze Edificio 18, 90128 Palermo, Italy
| | - Celine Bassinet
- Institut de radioprotection et de sûreté nucléaire, BP 17 - 92262 Fontenay-aux-Roses Cedex 31, Avenue de la Division Leclerc 92260 Fontenay-aux-Roses, Paris, France
| | - Christopher I Burbidge
- Environmental Protection Agency, Office of Radiological Protection, 3 Clonskeagh Square, Clonskeagh Road, Dublin 14, Ireland
| | - Virgilio Correcher
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de la Moncloa, Complutense, 40, 28040 Madrid, Spain
| | - Michael Discher
- University of Salzburg, Department of Geography and Geology, Hellbrunnerstraße 34, 5020 Salzburg, Austria
| | - Jon Eakins
- Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Chilton, Didcot, Oxford OX11 ORQ, UK
| | - Paola Fattibene
- Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
| | - Inci Güçlü
- Turkish Atomic Energy Authority, Mustafa Kemal Mahallesi, Dumlupinar Bulvari, No: 192, 06510, Çankaya - Ankara, Turkey
| | - Manuel Higueras
- Basque Center for Applied Mathematics, Alameda de Mazarredo 14, E-48009 Bilbao, Basque Country, Spain
| | - Eva Lund
- Department of Medical and Health Sciences, Linköping University, SE-581 85 Linköping, Sweden
| | - Nadica Maltar-Strmecki
- Ruder Boškovic Institute, Division of Physical Chemistry, Laboratory for Magnetic Resonances, Bijenicka cesta 54,10000 Zagreb, Croatia
| | - Stephen McKeever
- Oklahoma State University, 145 Physical Sciences, Campus, Stillwater, OK 74078, USA
| | - Christopher L Rääf
- Medicinsk strålningsfysik, Institutionen för Translationell Medicin, Lunds universitet, Skånes universitetssjukhus SUS, SE-205 02 Malmö, Sweden
| | - Sergey Sholom
- Oklahoma State University, 145 Physical Sciences, Campus, Stillwater, OK 74078, USA
| | - Ivan Veronese
- Università degli Studi di Milano, Department of Physics and National Institute of Nuclear Physics, Section of Milan, Via Celoria 16, 20133 - Milano, Italy
| | - Albrecht Wieser
- Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Institute of Radiation Protection, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany
| | - Clemens Woda
- Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Institute of Radiation Protection, Ingolstädter Landstraße 1, D-85764 Neuherberg, Germany
| | - Francois Trompier
- Institut de radioprotection et de sûreté nucléaire, BP 17 - 92262 Fontenay-aux-Roses Cedex 31, Avenue de la Division Leclerc 92260 Fontenay-aux-Roses, Paris, France
| |
Collapse
|
12
|
Grégoire E, Roy L, Buard V, Delbos M, Durand V, Martin-Bodiot C, Voisin P, Sorokine-Durm I, Vaurijoux A, Voisin P, Baldeyron C, Barquinero JF. Twenty years of FISH-based translocation analysis for retrospective ionizing radiation biodosimetry. Int J Radiat Biol 2018; 94:248-258. [DOI: 10.1080/09553002.2018.1427903] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Affiliation(s)
- Eric Grégoire
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - Laurence Roy
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - Valérie Buard
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - Martine Delbos
- Institut Fédératif de Biologie, CHU Toulouse Purpan, Toulouse, France
| | - Valérie Durand
- Bureau des Etudes Biomédicales chez l’Animal, Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France
| | - Cécile Martin-Bodiot
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - Pascale Voisin
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - Irène Sorokine-Durm
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - Aurélie Vaurijoux
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - Philippe Voisin
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | - Céline Baldeyron
- Laboratoire de Radiobiologie des expositions Accidentelles, Institut de Radioprotection et de Sureté Nucléaire (IRSN), Fontenay-aux-Roses Cedex, France
| | | |
Collapse
|
13
|
Wojcik A, Oestreicher U, Barrios L, Vral A, Terzoudi G, Ainsbury E, Rothkamm K, Trompier F, Kulka U. The RENEB operational basis: complement of established biodosimetric assays. Int J Radiat Biol 2016; 93:15-19. [DOI: 10.1080/09553002.2016.1235296] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Affiliation(s)
- Andrzej Wojcik
- Department of Molecular Biosciences, Stockholm University, Stockholm, Sweden and Jan Kochanowski University, Institute for Biology, Kielce, Poland
| | - Ursula Oestreicher
- Bundesamt fuer Strahlenschutz, Department Radiation Protection and Health, Neuherberg, Germany
| | | | - Anne Vral
- Faculty of Medicine and Health Sciences, Universiteit Gent, Gent, Belgium
| | - Georgia Terzoudi
- National Center for Scientific Research “Demokritos”, Athens, Greece
| | | | - Kai Rothkamm
- Public Health England, CRCE, Chilton, Didcot, Oxon, UK
- University Medical Center Hamburg, Laboratory of Radiation Biology, Hamburg, Germany
| | - Francois Trompier
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | - Ulrike Kulka
- Bundesamt fuer Strahlenschutz, Department Radiation Protection and Health, Neuherberg, Germany
| |
Collapse
|
14
|
Trompier F, Baumann M, Barrios L, Gregoire E, Abend M, Ainsbury E, Barnard S, Barquinero JF, Bautista JA, Brzozowska B, Perez-Calatayud J, De Angelis C, Domínguez I, Hadjidekova V, Kulka U, Mateos JC, Meschini R, Monteiro Gil O, Moquet J, Oestreicher U, Montoro Pastor A, Quintens R, Sebastià N, Sommer S, Stoyanov O, Thierens H, Terzoudi G, Villaescusa JI, Vral A, Wojcik A, Zafiropoulos D, Roy L. Investigation of the influence of calibration practices on cytogenetic laboratory performance for dose estimation. Int J Radiat Biol 2016; 93:118-126. [DOI: 10.1080/09553002.2016.1213455] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- François Trompier
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-roses, France
| | - Marion Baumann
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-roses, France
| | | | - Eric Gregoire
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-roses, France
| | - Michael Abend
- Bundeswehr Institut für Radiologie in verbindung mit der Universtität Ulm, Germany
| | - Elizabeth Ainsbury
- Public Health England Centre for Radiation, Chemical and Environmental Hazards (PHE), Chilton, UK
| | - Stephen Barnard
- Public Health England Centre for Radiation, Chemical and Environmental Hazards (PHE), Chilton, UK
| | | | | | - Beata Brzozowska
- Stockholm University, Department of Molecular Biosciences, Stockholm, Sweden
| | | | | | | | | | - Ulrike Kulka
- Bundesamt fuer Strahlenschutz, Department Radiation Protection and Health, Neuherberg, Germany
| | | | | | - Octávia Monteiro Gil
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Bobadela-LRS, Portugal
| | - Jayne Moquet
- Public Health England Centre for Radiation, Chemical and Environmental Hazards (PHE), Chilton, UK
| | - Ursula Oestreicher
- Bundesamt fuer Strahlenschutz, Department Radiation Protection and Health, Neuherberg, Germany
| | | | - Roel Quintens
- Belgian Nuclear Research Centre (SCK-CEN), Mol, Belgium
| | | | | | | | - Hubert Thierens
- Faculty of Medicine and Health Sciences, Ghent University, Gent, Belgium
| | - Georgia Terzoudi
- National Centre for Scientific Research “Demokritos”, Health Physics, Radiobiology & Cytogenetics, Athens, Greece
| | | | - Anne Vral
- Faculty of Medicine and Health Sciences, Ghent University, Gent, Belgium
| | - Andrzej Wojcik
- Stockholm University, Department of Molecular Biosciences, Stockholm, Sweden
| | | | - Laurence Roy
- Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-roses, France
| |
Collapse
|
15
|
Kulka U, Abend M, Ainsbury E, Badie C, Barquinero JF, Barrios L, Beinke C, Bortolin E, Cucu A, De Amicis A, Domínguez I, Fattibene P, Frøvig, AM, Gregoire E, Guogyte K, Hadjidekova V, Jaworska A, Kriehuber R, Lindholm C, Lloyd D, Lumniczky K, Lyng F, Meschini R, Mörtl S, Della Monaca S, Monteiro Gil O, Montoro A, Moquet J, Moreno M, Oestreicher U, Palitti F, Pantelias G, Patrono C, Piqueret-Stephan L, Port M, Prieto MJ, Quintens R, Ricoul M, Romm H, Roy L, Sáfrány G, Sabatier L, Sebastià N, Sommer S, Terzoudi G, Testa A, Thierens H, Turai I, Trompier F, Valente M, Vaz P, Voisin P, Vral A, Woda C, Zafiropoulos D, Wojcik A. RENEB – Running the European Network of biological dosimetry and physical retrospective dosimetry. Int J Radiat Biol 2016; 93:2-14. [DOI: 10.1080/09553002.2016.1230239] [Citation(s) in RCA: 39] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Affiliation(s)
- Ulrike Kulka
- Bundesamt für Strahlenschutz, Department Radiation Protection and Health, Oberschleissheim, Germany
| | - Michael Abend
- Bundeswehr Institute of Radiobiology affiliated to the University of Ulm, Munich, Germany
| | | | | | | | | | - Christina Beinke
- Bundeswehr Institute of Radiobiology affiliated to the University of Ulm, Munich, Germany
| | | | | | | | | | | | | | - Eric Gregoire
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | | | | | | | | | | | - David Lloyd
- affiliated to Public Health England, CRCE, Chilton, Didcot, Oxon, UK
| | - Katalin Lumniczky
- National Public Health Centre – National Research Directorate for Radiobiology and Radiohygiene, Budapest, Hungary
| | - Fiona Lyng
- Dublin Institute of Technology, Dublin, Ireland
| | | | - Simone Mörtl
- HelmholtzZentrum München, Oberschleissheim, Germany
| | | | - Octávia Monteiro Gil
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Bobadela-LRS, Portugal
| | - Alegria Montoro
- Hospital Universitario y Politécnico la Fe de la Comunidad Valenciana, Valencia, Spain
| | - Jayne Moquet
- Public Health England, CRCE, Chilton, Didcot, Oxon, UK
| | - Mercedes Moreno
- Servicio Madrileño de Salud – Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Ursula Oestreicher
- Bundesamt für Strahlenschutz, Department Radiation Protection and Health, Oberschleissheim, Germany
| | | | | | - Clarice Patrono
- Agenzia Nazionale per le Nuove Tecnologie, ĹEnergia e lo Sviluppo Economico Sostenibile, Rome, Italy
| | - Laure Piqueret-Stephan
- PROCyTOX, Commissariat à l’Energie Atomique et aux Energies Alternatives, Fontenay-aux-Roses, and Université Paris-Saclay, Paris, France
| | - Matthias Port
- Bundeswehr Institute of Radiobiology affiliated to the University of Ulm, Munich, Germany
| | - María Jesus Prieto
- Servicio Madrileño de Salud – Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | | | - Michelle Ricoul
- PROCyTOX, Commissariat à l’Energie Atomique et aux Energies Alternatives, Fontenay-aux-Roses, and Université Paris-Saclay, Paris, France
| | - Horst Romm
- Bundesamt für Strahlenschutz, Department Radiation Protection and Health, Oberschleissheim, Germany
| | - Laurence Roy
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | - Géza Sáfrány
- National Public Health Centre – National Research Directorate for Radiobiology and Radiohygiene, Budapest, Hungary
| | - Laure Sabatier
- PROCyTOX, Commissariat à l’Energie Atomique et aux Energies Alternatives, Fontenay-aux-Roses, and Université Paris-Saclay, Paris, France
| | - Natividad Sebastià
- Hospital Universitario y Politécnico la Fe de la Comunidad Valenciana, Valencia, Spain
| | | | - Georgia Terzoudi
- National Centre for Scientific Research Demokritos, Athens, Greece
| | - Antonella Testa
- Agenzia Nazionale per le Nuove Tecnologie, ĹEnergia e lo Sviluppo Economico Sostenibile, Rome, Italy
| | - Hubert Thierens
- Universiteit Gent, Faculty of Medicine and Health Sciences, Gent, Belgium
| | - Istvan Turai
- affiliated to National Public Health Centre – National Research Directorate for Radiobiology and Radiohygiene, Budapest, Hungary
| | - François Trompier
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | | | - Pedro Vaz
- Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Bobadela-LRS, Portugal
| | - Philippe Voisin
- affiliated to Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France
| | - Anne Vral
- Universiteit Gent, Faculty of Medicine and Health Sciences, Gent, Belgium
| | - Clemens Woda
- HelmholtzZentrum München, Oberschleissheim, Germany
| | | | - Andrzej Wojcik
- Stockholm University, Centre for Radiation Protection Research, Stockholm, Sweden
| |
Collapse
|
16
|
Brzozowska B, Ainsbury E, Baert A, Beaton-Green L, Barrios L, Barquinero JF, Bassinet C, Beinke C, Benedek A, Beukes P, Bortolin E, Buraczewska I, Burbidge C, De Amicis A, De Angelis C, Della Monaca S, Depuydt J, De Sanctis S, Dobos K, Domene MM, Domínguez I, Facco E, Fattibene P, Frenzel M, Monteiro Gil O, Gonon G, Gregoire E, Gruel G, Hadjidekova V, Hatzi VI, Hristova R, Jaworska A, Kis E, Kowalska M, Kulka U, Lista F, Lumniczky K, Martínez-López W, Meschini R, Moertl S, Moquet J, Noditi M, Oestreicher U, Orta Vázquez ML, Palma V, Pantelias G, Montoro Pastor A, Patrono C, Piqueret-Stephan L, Quattrini MC, Regalbuto E, Ricoul M, Roch-Lefevre S, Roy L, Sabatier L, Sarchiapone L, Sebastià N, Sommer S, Sun M, Suto Y, Terzoudi G, Trompier F, Vral A, Wilkins R, Zafiropoulos D, Wieser A, Woda C, Wojcik A. RENEB accident simulation exercise. Int J Radiat Biol 2016; 93:75-80. [PMID: 27559844 DOI: 10.1080/09553002.2016.1206230] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
PURPOSE The RENEB accident exercise was carried out in order to train the RENEB participants in coordinating and managing potentially large data sets that would be generated in case of a major radiological event. MATERIALS AND METHODS Each participant was offered the possibility to activate the network by sending an alerting email about a simulated radiation emergency. The same participant had to collect, compile and report capacity, triage categorization and exposure scenario results obtained from all other participants. The exercise was performed over 27 weeks and involved the network consisting of 28 institutes: 21 RENEB members, four candidates and three non-RENEB partners. RESULTS The duration of a single exercise never exceeded 10 days, while the response from the assisting laboratories never came later than within half a day. During each week of the exercise, around 4500 samples were reported by all service laboratories (SL) to be examined and 54 scenarios were coherently estimated by all laboratories (the standard deviation from the mean of all SL answers for a given scenario category and a set of data was not larger than 3 patient codes). CONCLUSIONS Each participant received training in both the role of a reference laboratory (activating the network) and of a service laboratory (responding to an activation request). The procedures in the case of radiological event were successfully established and tested.
Collapse
Affiliation(s)
- Beata Brzozowska
- a Stockholm University , Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute , Stockholm , Sweden.,b University of Warsaw , Faculty of Physics, Department of Biomedical Physics , Warsaw , Poland
| | | | - Annelot Baert
- d Faculty of Medicine and Health Sciences , Ghent University , Ghent , Belgium
| | | | | | | | - Celine Bassinet
- g Institut de Radioprotection et de Sûreté Nucléaire , France
| | - Christina Beinke
- h Bundeswehr Institut für Radiobiologie in Verbindung mit der Universtität Ulm , Munich , Germany
| | - Anett Benedek
- i National Public Health Centre - National Research Directorate for Radiobiology & Radiohygiene , Budapest , Hungary
| | - Philip Beukes
- j NRF iThemba LABS - Laboratory for Accelerator Based Sciences , Cape Town , South Africa
| | | | | | - Christopher Burbidge
- m Centro de Ciências e Tecnologias Nucleares , Instituto Superior Técnico, Universidade de Lisboa , Bobadela-LRS , Portugal
| | | | | | | | - Julie Depuydt
- d Faculty of Medicine and Health Sciences , Ghent University , Ghent , Belgium
| | | | - Katalin Dobos
- i National Public Health Centre - National Research Directorate for Radiobiology & Radiohygiene , Budapest , Hungary
| | - Mercedes Moreno Domene
- o Laboratorio de Dosimetría Biológica, Servicio de Oncología Radioterápica , Hospital General Universitario Gregorio Marañón , Madrid , Spain
| | | | - Eva Facco
- q Istituto Nazionale di Fisica Nucleare , Italy
| | | | - Monika Frenzel
- r PROCyTOX, Commissariat à l'Energie Atomique et aux Energies Alternatives , Fontenay-aux-Roses, and Université Paris-Saclay , France
| | - Octávia Monteiro Gil
- m Centro de Ciências e Tecnologias Nucleares , Instituto Superior Técnico, Universidade de Lisboa , Bobadela-LRS , Portugal
| | - Géraldine Gonon
- g Institut de Radioprotection et de Sûreté Nucléaire , France
| | - Eric Gregoire
- g Institut de Radioprotection et de Sûreté Nucléaire , France
| | - Gaëtan Gruel
- g Institut de Radioprotection et de Sûreté Nucléaire , France
| | | | - Vasiliki I Hatzi
- t National Centre for Scientific Research Demokritos , Athens , Greece
| | - Rositsa Hristova
- s National Centre for Radiobiology and Radiation Protection , Bulgaria
| | | | - Enikő Kis
- i National Public Health Centre - National Research Directorate for Radiobiology & Radiohygiene , Budapest , Hungary
| | - Maria Kowalska
- v Central Laboratory for Radiological Protection , Warsaw , Poland
| | - Ulrike Kulka
- w Bundesamt für Strahlenschutz , Oberschleissheim , Germany
| | - Florigio Lista
- n Army Medical and Veterinary Research Center , Rome , Italy
| | - Katalin Lumniczky
- i National Public Health Centre - National Research Directorate for Radiobiology & Radiohygiene , Budapest , Hungary
| | | | | | - Simone Moertl
- z Helmholtz Zentrum München , Oberschleissheim , Germany
| | - Jayne Moquet
- c Public Health England , Chilton , United Kingdom
| | | | | | | | - Valentina Palma
- ab Agenzia Nazionale per le Nuove Tecnologie, l'Energia e lo Sviluppo Economico Sostenibile , Italy
| | - Gabriel Pantelias
- t National Centre for Scientific Research Demokritos , Athens , Greece
| | | | - Clarice Patrono
- ab Agenzia Nazionale per le Nuove Tecnologie, l'Energia e lo Sviluppo Economico Sostenibile , Italy
| | - Laure Piqueret-Stephan
- r PROCyTOX, Commissariat à l'Energie Atomique et aux Energies Alternatives , Fontenay-aux-Roses, and Université Paris-Saclay , France
| | | | - Elisa Regalbuto
- n Army Medical and Veterinary Research Center , Rome , Italy
| | - Michelle Ricoul
- r PROCyTOX, Commissariat à l'Energie Atomique et aux Energies Alternatives , Fontenay-aux-Roses, and Université Paris-Saclay , France
| | | | - Laurence Roy
- g Institut de Radioprotection et de Sûreté Nucléaire , France
| | - Laure Sabatier
- r PROCyTOX, Commissariat à l'Energie Atomique et aux Energies Alternatives , Fontenay-aux-Roses, and Université Paris-Saclay , France
| | | | | | - Sylwester Sommer
- l Institute of Nuclear Chemistry and Technology , Warsaw , Poland
| | - Mingzhu Sun
- c Public Health England , Chilton , United Kingdom
| | - Yumiko Suto
- ad National Institute of Radiological Sciences , Chiba , Japan
| | - Georgia Terzoudi
- t National Centre for Scientific Research Demokritos , Athens , Greece
| | | | - Anne Vral
- d Faculty of Medicine and Health Sciences , Ghent University , Ghent , Belgium
| | | | | | | | - Clemens Woda
- z Helmholtz Zentrum München , Oberschleissheim , Germany
| | - Andrzej Wojcik
- a Stockholm University , Centre for Radiation Protection Research, Department of Molecular Biosciences, The Wenner-Gren Institute , Stockholm , Sweden.,ae Jan Kochanowski University , Kielce , Poland
| |
Collapse
|
17
|
Gregoire E, Ainsbury L, Barrios L, Bassinet C, Fattibene P, Kulka U, Oestreicher U, Pantelias G, Terzoudi G, Trompier F, Voisin P, Vral A, Wojcik A, Roy L. The harmonization process to set up and maintain an operational biological and physical retrospective dosimetry network: QA QM applied to the RENEB network. Int J Radiat Biol 2016; 93:81-86. [DOI: 10.1080/09553002.2016.1206232] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Eric Gregoire
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-Aux-Roses, France
| | - Liz Ainsbury
- Public Health England, CRCE, Chilton, Didcot, Oxon, UK
| | | | - Céline Bassinet
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-Aux-Roses, France
| | | | - Ulrike Kulka
- Bundesamt fuer Strahlenschutz, Department Radiation Protection and Health, Neuherberg, Germany
| | - Ursula Oestreicher
- Bundesamt fuer Strahlenschutz, Department Radiation Protection and Health, Neuherberg, Germany
| | - Gabriel Pantelias
- National Centre for Scientific Research ‘Demokritos’, Athens, Greece
| | - Georgia Terzoudi
- National Centre for Scientific Research ‘Demokritos’, Athens, Greece
| | - Francois Trompier
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-Aux-Roses, France
| | - Philippe Voisin
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-Aux-Roses, France
| | - Anne Vral
- Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
| | | | - Laurence Roy
- Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-Aux-Roses, France
| |
Collapse
|